AKA-333
(+)-Catechin

Cat. No.

AKA-333

CAS No.

154-23-4

MF

C15H14O6

MW

290.27

(+)-Catechin is a natural active polyphenol compound with biological activities such as antioxidant and anti-inflammatory effects, and it is also a core raw material and synthetic intermediate for various pharmaceutical and health product APIs.
Package Specification Stock Quantity Request Quote
20mg 98% In Stock
Add
100mg 98% In Stock
Add
1g 98% In Stock
Add
Technical Service
Need help? Our team of experienced experts is here for you with full support.
86-28-85159085
info@aktin.com
Inquiry
Technical Data
Description
Documents
Storage and Shipping
References
English Name
(+)-Catechin
CAS No.
154-23-4
MF
C15H14O6
MW
290.27
Specification
98%
Description
Product:    (+)-Catechin
CAS No.:    154-23-4
Molecular Formula:    C15H14O6
Molecular Weight:    290.27 
Chemical Name:    (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol
Specification:    98%min by HPLC
Packing:    10mg, 20mg, 50mg, 100mg, 500mg, 1g, 5g, 10g, 1kg
Availability:    In stock
Grade:    For research only
Documents
Can't find the right version? Our team of experienced experts is here for you with full support. 
Contact Us
Storage and Shipping
Store under nitrogen, protected from light, in a tightly sealed container, refrigerated or frozen.
References
Related Products
AKA-344
D-Menthol

CAS No.:15356-60-2

MF:C10H20O

View Details
AKA-343
Fmoc-Asn(Trt)- Asn(Trt)-OH

CAS No.:844641-64-1

MF:C61H52N4O7

View Details
AKA-342
Guggulsterone

CAS No.:95975-55-6

MF:C21H28O2

View Details
AKA-341
Cabergoline

CAS No.:81409-90-7

MF:C26H37N5O2

View Details
AKA-340
Halofuginone hydrochloride

CAS No.:1217623-74-9

MF:C16H18BrCl2N3O3

View Details
AKA-339
Tetrahydropalmatine

CAS No.:2934-97-6

MF:C21H25NO4

View Details
AKA-338
Isofangchinoline

CAS No.:33889-68-8

MF:C37H40N2O6

View Details
AKA-337
N-(3-Acetoacetamidopropyl)methacrylamide

CAS No.:71938-39-1

MF:C11H18N2O3

View Details
AKA-336
Validamycin A

CAS No.:37248-47-8

MF:C20H35NO13

View Details
AKA-335
alpha-Phellandrene

CAS No.:99-83-2

MF:C10H16

View Details
* Some statements have not been evaluated by national authorities.
* Some products are not intended to diagnose, treat, cure, or prevent any disease.
* For literature supporting, please contact us directly.
Cart
TotalProducts
Request Quote
  • China
  • Afghanistan
  • Albania
  • Algeria
  • Andorra
  • Angola
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Brazil
  • Brunei
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Central African Republic
  • Chad
  • Chile
  • Colombia
  • Comoros
  • Congo (Brazzaville)
  • Congo (Kinshasa)
  • Cook Islands
  • Costa Rica
  • Côte d'Ivoire
  • Croatia
  • Cuba
  • Cyprus
  • Czech Republic
  • Denmark
  • Djibouti
  • Dominica
  • Dominican Republic
  • East Timor (Timor-Leste)
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Eswatini
  • Ethiopia
  • Fiji
  • Finland
  • France
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Greece
  • Grenada
  • Guatemala
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Honduras
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • South Korea
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Libya
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Mauritania
  • Mauritius
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Morocco
  • Mozambique
  • Myanmar (Burma)
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • North Macedonia
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Qatar
  • Romania
  • Russia
  • Rwanda
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Vincent and the Grenadines
  • Samoa
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • Spain
  • Sri Lanka
  • Sudan
  • South Sudan
  • Suriname
  • Sweden
  • Switzerland
  • Syria
  • Tajikistan
  • Tanzania
  • Thailand
  • Togo
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates (UAE)
  • United Kingdom (UK)
  • United States (US)
  • Uruguay
  • Uzbekistan
  • Vanuatu
  • Vatican City
  • Venezuela
  • Vietnam
  • Yemen
  • Zambia
  • Zimbabwe
  • Beijing-Beijing
  • Tianjin-Tianjin
  • Hebei-Shijiazhuang
  • Shanxi-Taiyuan
  • Inner Mongolia-Hohhot
  • Liaoning-Shenyang
  • Jilin-Changchun
  • Heilongjiang-Harbin
  • Shanghai-Shanghai
  • Jiangsu-Nanjing
  • Zhejiang-Hangzhou
  • Anhui-Hefei
  • Fujian-Fuzhou
  • Jiangxi-Nanchang
  • Shandong-Jinan
  • Henan-Zhengzhou
  • Hubei-Wuhan
  • Hunan-Changsha
  • Guangdong-Guangzhou
  • Guangxi-Nanning
  • Hainan-Haikou
  • Chongqing-Chongqing
  • Sichuan-Chengdu
  • Guizhou-Guiyang
  • Yunnan-Kunming
  • Tibet-Lhasa
  • Shaanxi-Xi'an
  • Gansu-Lanzhou
  • Qinghai-Xining
  • Ningxia-Yinchuan
  • Xinjiang-Urumqi
  • Hong Kong-Hong Kong
  • Macao-Macao
  • Taiwan-Taipei